close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eton Pharmaceuticals, Inc. - Common Stock (NQ:ETON)

55.17 -1.92 (-3.36%)
Streaming Delayed Price Updated: 3:04 PM EDT, Sep 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 303,623
Open 56.96
Bid (Size) 55.07 (900)
Ask (Size) 55.27 (500)
Prev. Close 57.09
Today's Range 54.24 - 56.97
52wk Range 14.27 - 66.37
Shares Outstanding 25,688,062
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals (ETON) Q2 2026 Earnings Call Transcript ↗
Revenue surged 99% year-over-year on HEMANGEOL relaunch and rare disease portfolio growth. 
Via The Motley Fool
Topics Earnings

Performance

YTD
+239.3%
+239.3%
1 Month
-14.4%
-14.4%
3 Month
+64.7%
+64.7%
6 Month
+140.2%
+140.2%
1 Year
+200.3%
+200.3%

More News

Read More
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
Eton Pharmaceuticals (NASDAQ:ETON) Soars on Q1 Beat, Raises Full-Year Guidance ↗
Via Chartmill
News headline image
Why Eton Pharmaceuticals Is Top of the Class Today ↗
Via The Motley Fool
Keep an eye on the top gainers and losers in Friday's session. ↗
Via Chartmill
Friday's session: gap up and gap down stocks ↗
Via Chartmill
Discover the top movers in Friday's pre-market session. ↗
Via Chartmill
News headline image
Eton Pharmaceuticals Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Eton Pharmaceuticals Q2 2026 Earnings Call: Complete Transcript ↗
Via Benzinga
Topics Earnings
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI® (hydrocortisone) Oral Solution
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine)
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton (ETON) Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Eton Pharmaceuticals Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Eton Pharmaceuticals Reports First Quarter 2026 Financial Results
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals to Participate in Upcoming Investor Conferences
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals relaunches HEMANGEOL® (propranolol) Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals Announces Initiation of Clinical Study for Product Candidate ET-700
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharmaceuticals Announces CFO Succession Plan
From Eton Pharmaceuticals
Via GlobeNewswire
News headline image
Eton Pharma (ETON) Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings

Frequently Asked Questions

Is Eton Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Eton Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Eton Pharmaceuticals, Inc. - Common Stock trade on?
Eton Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Eton Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Eton Pharmaceuticals, Inc. - Common Stock is ETON on the Nasdaq Stock Market
What is the current price of Eton Pharmaceuticals, Inc. - Common Stock?
The current price of Eton Pharmaceuticals, Inc. - Common Stock is 55.17
When was Eton Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Eton Pharmaceuticals, Inc. - Common Stock was at 09/23/26 03:04 PM ET
What is the market capitalization of Eton Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Eton Pharmaceuticals, Inc. - Common Stock is 1.42B
How many shares of Eton Pharmaceuticals, Inc. - Common Stock are outstanding?
Eton Pharmaceuticals, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.